Amnion derived adherent cells
US9198938B2 · kind B2 · utility
4Cited by
148References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 26, 2012 |
| Grant date | Dec 1, 2015 |
| Priority date | — |
| Expiry date | Feb 2, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K35/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are novel angiogenic cells from amnion, referred to as amnion derived adherent cells, and populations of, and compositions comprising, such cells. Further provided herein are methods of obtaining such cells and methods of using the cells in the treatment of individuals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.